amylase 39150 UNT / lipase 10440 UNT / protease 39150 UNT Oral Tablet [Viokace]
RxNorm concept 1247388, branded drug (sbd). Prescribable name: Viokace 10,440 UNT / 39,150 UNT / 39,150 UNT Oral Tablet.
- RxCUI
- 1247388
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1247388 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Viokace 10 (amylase 39,150 UNT / lipase 10,440 UNT / protease 39,150 UNT) Oral Tablet; Viokase 10 Oral Tablet; Viokase 20 (amylases 39,150 UNT / endopeptidases 39,150 UNT / lipase 10,440 UNT) Oral Tablet
Related concepts
- amylase 39150 UNT (SCDC, consists of)
- protease 39150 UNT (SCDC, consists of)
- lipase 10440 UNT (SCDC, consists of)
- amylase 39150 UNT / lipase 10440 UNT / protease 39150 UNT [Viokace] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Viokace (BN, has ingredient)
- amylase 39150 UNT / lipase 10440 UNT / protease 39150 UNT Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 58914011210
- 73562010410
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1247388 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1247388 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1247388. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.